Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
37.64
+0.33 (0.88%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Ultragenyx Pharmaceutical (RARE) Revenue by Segment
History
| Date | Other | Product |
|---|---|---|
| Dec 31, 2024 | 274.71M | 285.47M |
| Sep 30, 2024 | 257.40M | 265.30M |
| Jun 30, 2024 | 250.90M | 230.30M |
| Mar 31, 2024 | 243.80M | 198.70M |
| Dec 31, 2023 | 253.80M | 180.40M |
| Sep 30, 2023 | 252.60M | 157.60M |
| Jun 30, 2023 | 245.10M | 147.80M |
| Mar 31, 2023 | 237.50M | 136.40M |
| Dec 31, 2022 | 234.40M | 118.90M |
| Sep 30, 2022 | 223.00M | 110.20M |
| Jun 30, 2022 | 234.40M | 99.70M |
| Mar 31, 2022 | 244.50M | 87.20M |
| Dec 31, 2021 | 274.20M | 77.00M |
| Sep 30, 2021 | 289.70M | 69.80M |
| Jun 30, 2021 | 300.30M | 59.00M |
| Mar 31, 2021 | 285.40M | 48.80M |
| Dec 31, 2020 | 232.30M | 38.80M |
| Sep 30, 2020 | 182.10M | 33.00M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.